CEPID CancerThera brings Campinas public school students closer to cancer research at Viva Ciência 2026
Between May 19 and 21, the Exploratory Science Museum of the State University of Campinas (MEC/Unicamp) became a vibrant hub
Principal investigator at CEPID CancerThera, Elba Etchebehere joins the advisory board of a new journal from The Lancet group
Dr. Elba Etchebehere, nuclear medicine physician and principal investigator at CEPID CancerThera, has just been appointed as a member of
Study by CEPID CancerThera reveals that social vulnerability interferes with the prognosis of cancer patients in Campinas
Campinas has a Human Development Index (HDI) considered very high (0.805) and an urbanization rate of 98.28%, figures often comparable
Stomach cancer: study by researchers from CEPID CancerThera shows how the severity of the disease can be assessed based on a computer program developed with AI
In recent years, the way Oncology classifies the severity of a cancer has gained a new resource thanks to the
Researchers from CEPID CancerThera participate in the 13th Alpha Therapy Symposium and the 19th Edwaldo Camargo Symposium – Beta Therapy; international events were held concurrently in Rio de Janeiro
Between April 14 and 16, the Windsor Barra Convention Center, in Rio de Janeiro (RJ), hosted an important meeting for
AI-powered software developed at CEPID CancerThera supports the analysis of body composition in cancer patients
A multidisciplinary team, combining expertise from Physics, Oncology, and Nutrition, developed an unprecedented mathematical model based on Artificial Intelligence (AI)
HC/Unicamp restructures Nuclear Medicine Service area and inaugurates unprecedented equipment in public hospitals in Latin America with support from CEPID CancerThera
The Hospital de Clínicas of the University of Campinas (HC/Unicamp) celebrated, on April 10, a historic milestone for Brazilian public
Researcher affiliated with CEPID CancerThera, Fabio Luiz Navarro Marques is elected president of SBBN with a focus on innovation and institutional articulation
The Brazilian Society of Nuclear Biosciences (SBBN) begins a new institutional cycle with the inauguration of its president for the
Researchers from CEPID CancerThera propose using the Brain-to-Liver Ratio to predict the aggressiveness of bone marrow cancer and measure patient survival based on PET/CT images
In imaging exams that track the body’s energy consumption, the brain is usually the main protagonist, glowing intensely on the
3rd CancerThera Congress consolidates multidisciplinary integration and advances in Cancer Theranostics
The 3rd CancerThera Congress, held from March 11 to 13, 2026, at the School of Medical Sciences of the State